Mench Capital Corp. is a Canadian merchant banking firm that provides sophisticated corporate finance advisory consulting services and access to private or public capital to established, mid-market companies in order to achieve their vision. R. Bruce Fair is President and founder.


Mench Capital Corp. has participated in and/ or originated in the formation of in excess of $300M in private and public equity transactions over the past 19 years mainly targeted in Canadian resource & non-bank private lending focused industries.


Please refer to our website to learn more about us.

NEXT EDGE PRIVATE DEBT FUND
The Next Edge Private Debt Fund (the 'Fund') aims to provide consistent risk-adjusted returns with minimal volatility and low correlation to traditional asset classes by investing primarily in a diversified portfolio of trade finance and factoring investments. To achieve its investment objective the Fund will allocate capital to a select number of loan originators and credit managers who are recognized leaders in the North American direct lending marketplace.

VICTORY PARK CAPITAL SPECIALTY LENDING STRATEGY
Victory Park Capital Advisors LLC ("VPC") is a privately held, SEC-registered, global alternative investment firm. Through its complimentary business strategies, VPC finances both emerging and established businesses across various industries with the goal of accelerating value creation. The firm's differentiated offerings leverage broad special situations and credit structuring expertise, disciplined deal origination, creative financing capabilities and an extensive network of industry relationships. VPC was founded in 2007 and is headquartered in Chicago with additional offices in New York and Los Angeles.

NEXT EDGE BIO-TECH PLUS FUND
The Next Edge Bio-Tech Plus Fund will provide access to a diversified portfolio of predominately small-to-midcap global biotech and healthcare companies -- potential winners of tomorrow. From the universe of healthcare companies, the Fund will focus on those companies conducting late-stage clinical trials, or early commercialization: a 3 year window in a decade long process to develop a drug for market.

ALTERNATIVE ENERGY
Provide advisory role services and financing solutions to the Alternative Energy sector. A key area of expertise is in the commercial scale solar and energy efficiency project finance. Mench Capital Corp. has previously participated in the Ontario Feed-In Tariff (FIT) Program to take solar energy projects to a viable commercial level.